Aridol is manufactured by Pharmaxis in our factory in Sydney Australia. In countries outside of Australia it is supplied to pharmacies by third party local distributors and wholesaler networks. Within Australia Aridol is supplied direct to pharmacies and respiratory laboratories from our manufacturing facility. Pharmaxis and its distributors hold a number of months of Aridol stock (typically more than three months) and our manufacturing facility is still fully operational. We are taking a series of measures to ensure our staff remain safe, our facility continues to produce Aridol and we maintain our global stock levels.

For specific enquiries on the availability of Aridol in your country please contact your local distributor.

Please also be aware of your local clinical guidelines for bronchial challenge testing during the COVID-19 pandemic.

Announcement icon

COVID-19: Information for Respiratory Laboratories and Pharmacies